Pulmatrix, inc. (PULM)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13
Revenues

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

0

0

-

306

0

0

0

-

0

-

-

835

992

1,582

1,492

1,201

926

305

143

38

38

8

0

0

0

0

Operating expenses
Research and development

15,956

12,845

11,858

11,617

12,466

13,511

12,880

12,442

11,792

10,243

10,427

9,316

8,394

10,152

9,844

10,530

9,699

7,187

5,340

5,076

5,195

4,594

4,370

2,936

1,382

0

0

0

General and administrative

8,714

8,489

8,946

8,930

7,917

7,976

7,770

8,022

7,973

7,567

7,569

7,098

7,246

8,015

8,273

9,842

17,507

17,032

15,627

13,230

0

-

0

0

-

-

-

-

Impairment of goodwill

-

7,268

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of intangibles, net of tax provision

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

1,736

0

0

0

Total operating expenses

31,144

28,602

28,072

27,815

21,177

21,487

20,650

20,464

19,765

17,810

20,955

19,373

23,174

25,701

22,692

24,947

27,206

24,219

21,369

18,681

9,643

7,780

6,722

5,092

3,118

0

0

0

Loss from operations

-20,472

-20,692

-21,694

-22,843

-21,024

-21,181

-20,497

-19,976

-19,277

-17,475

-20,502

-19,194

-22,735

-24,866

-21,700

-23,365

-25,714

-23,018

-20,443

-18,376

-9,508

-7,750

-6,692

-5,092

-3,118

0

0

0

Other income (expense)
Other income/(expense)
Interest expense

-

-

-

-

-

292

317

470

562

643

721

793

845

881

894

889

992

953

8,616

14,009

0

-

0

0

-

-

-

-

Loss on the conversion of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Fair value adjustment of preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,309

-654

-1,777

0

-

0

0

-

-

-

-

Fair value adjustment of derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,291

0

0

0

-

-

-

-

-

-

-

Interest income

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Settlement expense

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses, net

-3

-5

-3

100

17

19

23

27

11

28

-45

14

17

-2

0

0

0

-

0

0

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

0

Total other income/(expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

0

Net loss

-20,126

-20,596

-21,776

-23,037

-21,381

-21,446

-20,749

-20,385

-19,794

-18,056

-23,362

-22,067

-25,657

-27,843

-22,548

-24,323

-30,033

-26,167

-23,344

-29,546

-21,590

-20,776

-19,722

-9,582

-3,118

0

0

0

Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-32,779

-34,801

0

-

0

0

-

-

-

-

Net loss per share, basic and diluted

-0.23

0.10

-0.18

-0.41

-0.74

-2.39

-1.03

-1.34

-0.24

-8.60

-0.22

-0.29

-0.21

-0.67

-0.21

-0.62

-0.38

12.43

-0.34

-5.77

-9.55

-0.35

-59.60

-2.21

-0.46

-0.33

-0.50

-0.24

Weighted average shares used to compute basic and diluted net loss per share

20,469

20,480

20,294

19,216

6,944

2,187

4,692

4,610

21,876

-48,796

20,200

19,553

16,791

14,851

14,850

14,804

14,754

14,936

14,654

2,580

188

4,848

187

3,145

2,145

2,000

2,000

2,000